111 related articles for article (PubMed ID: 14694016)
1. Hepatocyte growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy: its relationship with vascular endothelial growth factor and retinopathy activity.
Simó R; Lecube A; García-Arumí J; Carrasco E; Hernández C
Diabetes Care; 2004 Jan; 27(1):287-8. PubMed ID: 14694016
[No Abstract] [Full Text] [Related]
2. Increased levels of alphaB-crystallin in vitreous fluid of patients with proliferative diabetic retinopathy and correlation with vascular endothelial growth factor.
Chen W; Lu Q; Lu L; Guan H
Clin Exp Ophthalmol; 2017 May; 45(4):379-384. PubMed ID: 27928876
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders.
Katsura Y; Okano T; Noritake M; Kosano H; Nishigori H; Kado S; Matsuoka T
Diabetes Care; 1998 Oct; 21(10):1759-63. PubMed ID: 9773744
[TBL] [Abstract][Full Text] [Related]
4. Intravitreous levels of hepatocyte growth factor/scatter factor and vascular cell adhesion molecule-1 in the vitreous fluid of diabetic patients with proliferative retinopathy.
Hernández C; Carrasco E; García-Arumí J; Maria Segura R; Simó R
Diabetes Metab; 2004 Sep; 30(4):341-6. PubMed ID: 15525877
[TBL] [Abstract][Full Text] [Related]
5. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study.
Hernández C; Burgos R; Cantón A; García-Arumí J; Segura RM; Simó R
Diabetes Care; 2001 Mar; 24(3):516-21. PubMed ID: 11289478
[TBL] [Abstract][Full Text] [Related]
6. PERSISTENT OVERPRODUCTION OF INTRAOCULAR VASCULAR ENDOTHELIAL GROWTH FACTOR AS A CAUSE OF LATE VITREOUS HEMORRHAGE AFTER VITRECTOMY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
Wakabayashi Y; Usui Y; Tsubota K; Ueda S; Umazume K; Muramatsu D; Goto H
Retina; 2017 Dec; 37(12):2317-2325. PubMed ID: 28098727
[TBL] [Abstract][Full Text] [Related]
7. IGF-I of serum and vitreous fluid in patients with diabetic proliferative retinopathy.
Lee HC; Lee KW; Chung CH; Chung YS; Lee EJ; Lim SK; Kim KR; Huh KB; Lee SC; Kwon OW
Diabetes Res Clin Pract; 1994 Jun; 24(2):85-8. PubMed ID: 7956713
[TBL] [Abstract][Full Text] [Related]
8. Comparison of vitreous and plasma levels of vascular endothelial growth factor, interleukin-6 and hepatocyte growth factor in diabetic and non-diabetic retinal detachment cases.
Kocak N; Alacacioglu I; Kaynak S; Ozcan MA; Celik O; Yuksel F; Piskin O; Oner H; Saatci AO; Ergin M
Ann Ophthalmol (Skokie); 2010; 42 Spec No():10-4. PubMed ID: 21138144
[TBL] [Abstract][Full Text] [Related]
9. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.
Burgos R; Simó R; Audí L; Mateo C; Mesa J; García-Ramírez M; Carrascosa A
Diabetologia; 1997 Sep; 40(9):1107-9. PubMed ID: 9300249
[TBL] [Abstract][Full Text] [Related]
10. RANDOMIZED CONTROLLED STUDY OF INTRAVITREAL BEVACIZUMAB 0.16 MG INJECTED ONE DAY BEFORE SURGERY FOR PROLIFERATIVE DIABETIC RETINOPATHY.
Manabe A; Shimada H; Hattori T; Nakashizuka H; Yuzawa M
Retina; 2015 Sep; 35(9):1800-7. PubMed ID: 25932549
[TBL] [Abstract][Full Text] [Related]
11. Changes in vitreous concentrations of human hepatocyte growth factor (hHGF) in proliferative diabetic retinopathy: implications for intraocular hHGF production.
Nishimura M; Ikeda T; Ushiyama M; Kinoshita S; Yoshimura M
Clin Sci (Lond); 2000 Jan; 98(1):9-14. PubMed ID: 10600653
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H
N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858
[TBL] [Abstract][Full Text] [Related]
13. Effect of intravitreal bevacizumab on serum, aqueous, and vitreous humor levels of erythropoietin in patients with proliferative diabetic retinopathy.
Cancarini A; Costagliola C; Dell'omo R; Romano M; Morescalchi F; Agnifili L; Ruggeri G; Semeraro F
Minerva Endocrinol; 2014 Dec; 39(4):305-11. PubMed ID: 25371057
[TBL] [Abstract][Full Text] [Related]
14. Positive correlation between vitreous levels of advanced glycation end products and vascular endothelial growth factor in patients with diabetic retinopathy sufficiently treated with photocoagulation.
Yokoi M; Yamagishi S; Takeuchi M; Matsui T; Yoshida Y; Ohgami K; Amano-Okamoto T; Ohno S
Br J Ophthalmol; 2007 Mar; 91(3):397-8. PubMed ID: 17322470
[No Abstract] [Full Text] [Related]
15. Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin II.
Funatsu H; Yamashita H; Noma H; Mimura T; Sakata K; Hori S
Br J Ophthalmol; 2004 Aug; 88(8):1064-8. PubMed ID: 15258026
[TBL] [Abstract][Full Text] [Related]
16. Risk evaluation of outcome of vitreous surgery based on vitreous levels of cytokines.
Funatsu H; Yamashita H; Mimura T; Noma H; Nakamura S; Hori S
Eye (Lond); 2007 Mar; 21(3):377-82. PubMed ID: 16410812
[TBL] [Abstract][Full Text] [Related]
17. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
Itakura H; Kishi S; Kotajima N; Murakami M
Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
[TBL] [Abstract][Full Text] [Related]
18. Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy.
Malik RA; Li C; Aziz W; Olson JA; Vohra A; McHardy KC; Forrester JV; Boulton AJ; Wilson PB; Liu D; McLeod D; Kumar S
J Cell Mol Med; 2005; 9(3):692-7. PubMed ID: 16202216
[TBL] [Abstract][Full Text] [Related]
19. Level of Vascular Endothelial Growth Factor in the Vitreous Fluid of Proliferative Diabetic Retinopathy Patients and Prognosis after Vitrectomy.
Suzuki Y; Suzuki K; Kudo T; Metoki T; Nakazawa M
Ophthalmologica; 2016; 236(3):133-138. PubMed ID: 27794575
[TBL] [Abstract][Full Text] [Related]
20. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
